SCNX (Scienture Holdings) Cyclically Adjusted FCF per Share: $-2.84 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SCNX Scienture Holdings Inc SCNX
45 GF Score
Price $0.44
GF Value $0.52
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Scienture Holdings Cyclically Adjusted FCF per Share?

Scienture Holdings SCNX -5.15% 45 Cyclically Adjusted FCF per Share is $-2.84 as of Jun. 2026. GuruFocus rates SCNX with a GF Score™ of 45/100 and a GF Value™ of $0.52 (Modestly Undervalued). The stock has 9 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Scienture Holdings's adjusted free cash flow per share for the three months ended in Jun. 2026 was $-0.232. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-2.84 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 7.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 80.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Scienture Holdings was 90.70% per year. The lowest was 7.60% per year. And the median was 90.35% per year.

As of today (2026-08-23), Scienture Holdings's current stock price is $0.443. Scienture Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was $-2.84. Scienture Holdings's Cyclically Adjusted Price-to-FCF of today is .


Scienture Holdings  (NAS:SCNX) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Scienture Holdings Cyclically Adjusted FCF per Share Related Terms


Scienture Holdings Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Scienture Holdings's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scienture Holdings Cyclically Adjusted FCF per Share Chart

Scienture Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4,039.59 -3.62 -3.01 -3.44 -2.86

Scienture Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.33 -3.31 -2.86 -2.89 -2.84

SCNX vs HEWA, BLMH, PMHS: Cyclically Adjusted FCF per Share Comparison

For the Pharmaceutical Retailers subindustry, Scienture Holdings's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scienture Holdings Cyclically Adjusted Price-to-FCF vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Scienture Holdings's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Scienture Holdings's Cyclically Adjusted Price-to-FCF falls into.


SCNX
45GF Score
Scienture Holdings Inc SCNX
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scienture Holdings Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Scienture Holdings's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.232/333.9520*333.9520
=-0.232

Current CPI (Jun. 2026) = 333.9520.

Scienture Holdings Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 -0.989 241.428 -1.368
201612 -1.733 241.432 -2.397
201703 -0.126 243.801 -0.173
201706 0.141 244.955 0.192
201709 0.309 246.819 0.418
201712 0.140 246.524 0.190
201803 0.177 249.554 0.237
201806 0.209 251.989 0.277
201809 0.220 252.439 0.291
201812 0.106 251.233 0.141
201903 -0.315 254.202 -0.414
201906 0.114 256.143 0.149
201909 1.002 256.759 1.303
201912 -0.421 256.974 -0.547
202003 -0.879 258.115 -1.137
202006 -7.073 257.797 -9.162
202009 4.615 260.280 5.921
202012 -1.326 260.474 -1.700
202103 -1.315 264.877 -1.658
202106 -1.277 271.696 -1.570
202109 -1.357 274.310 -1.652
202112 -0.785 278.802 -0.940
202203 -1.837 287.504 -2.134
202206 -2.161 296.311 -2.436
202209 -1.045 296.808 -1.176
202212 1.918 296.797 2.158
202303 -1.389 301.836 -1.537
202306 0.483 305.109 0.529
202309 -0.255 307.789 -0.277
202312 -0.388 306.746 -0.422
202403 -8.043 312.332 -8.600
202406 3.003 314.175 3.192
202409 -2.270 315.301 -2.404
202412 -0.332 315.605 -0.351
202503 -0.314 319.799 -0.328
202506 -0.497 322.561 -0.515
202509 0.094 324.800 0.097
202512 -0.279 324.054 -0.288
202603 -0.072 330.213 -0.073
202606 -0.232 333.952 -0.232

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-2.84 mean?
Scienture Holdings (SCNX) has a Cyclically Adjusted FCF per Share of $-2.84 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Scienture Holdings and its competitors.
Is Scienture Holdings' Cyclically Adjusted FCF per Share too high?
Scienture Holdings' current Cyclically Adjusted FCF per Share is $-2.84. Overall, Scienture Holdings has a GF Score™ of 45/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Scienture Holdings' Cyclically Adjusted FCF per Share compare to HEWA and BLMH?
Scienture Holdings' Cyclically Adjusted FCF per Share of $-2.84 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted FCF per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Scienture Holdings and its competitors. Scienture Holdings's current Cyclically Adjusted FCF per Share is $-2.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scienture Holdings stock overvalued right now?
Based on GuruFocus' analysis, Scienture Holdings (SCNX) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.52, compared to a current price of $0.44 — trading 14.8% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $-2.84. Scienture Holdings' overall GF Score™ is 45/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Scienture Holdings (SCNX), the current Cyclically Adjusted FCF per Share is $-2.84 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scienture Holdings (SCNX) Overvalued in 2026?

Based on GuruFocus' analysis, Scienture Holdings stock appears to be undervalued. The current stock price of $0.44 is trading 14.8% below its estimated GF Value™ of $0.52. GuruFocus considers Scienture Holdings to be Modestly Undervalued.

Key valuation signals for SCNX:

  • Cyclically Adjusted FCF per Share: $-2.84
  • GF Value™: $0.52 vs. price of $0.44 (14.8% below fair value)
  • GF Score™: 45/100 with 9 warning signs

No single metric tells the full story. See the SCNX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Scienture Holdings Business Description

Other Exchanges 4E4:Germany
Address 20 Austin Boulevard, Commack, NY, USA, 11725
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
45GF Score

Get the complete analysis for SCNX

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.44
Price
$0.52
GF Value